David A. Sallman (2020) “To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia”, Haematologica. Pavia, Italy, 105(6), pp. 1470-1472. doi: 10.3324/haematol.2020.249060.